Abstract
The impact of cytoreductive radical prostatectomy on oncological outcome in patients with prostate cancer and limited number of bone metastases is unclear. Data from cancer registries, multi-institutional databases and a single institutional case-control study indicate a possible benefit of combined cytoreduction and hormonal therapy compared to hormonal therapy alone. However, the results may be biased by a number of factors. The evidence from studies on cytoreductive prostatectomy is reviewed.
Original language | English |
---|---|
Journal | Scandinavian Journal of Urology |
Volume | 52 |
Issue number | 1 |
Pages (from-to) | 1-7 |
ISSN | 0036-5599 |
DOIs | |
Publication status | Published - 2 Jan 2018 |